Welcome to the Dawnbreaker Medical Portal. The content of this site is provided by Dawnbreaker as service to those developing and improving drugs, biologics and medical devices. Much of the portal content is built around the Food and Drug Administration’s regulatory processes that must be followed to gain marketing approval. Understanding and meeting these regulatory requirements significantly enhances the likelihood of successful product development. This site contains several sections including the newsfeed to the right, descriptions of relevant FDA centers, FDA’s position on biotechnology and overviews on drugs, biologics, medical devices and veterinary products. Please explore this portal and provide us with your feedback and ideas for additional topics.
Diabetes Can Take a Toll on Your Emotions
(May 17, 19:05) Drugs.com MedNews
Looking Away As You Get Needle Does Lower Pain, Study Shows
(May 17, 16:05) Drugs.com MedNews
FDA Approves Generic Versions of Plavix
(May 17, 16:05) Drugs.com MedNews
Generic Versions of Blood-Thinning Plavix Approved
(May 17, 15:05) Drugs.com MedNews
Zithromax (azithromycin): FDA Statement on risk of cardiovascular death
(May 17, 14:45) FDA Medwatch RSS
Parents Often Lose Sleep Over Child's Epilepsy, Study Finds
(May 17, 14:05) Drugs.com MedNews
